By Suevon Lee ( June 7, 2016, 1:20 AM EDT) -- Merck forfeited its right to enforce two patents covering an ingredient in hepatitis C drugs against rival Gilead due to "numerous unconscionable acts" before and during trial, a California federal judge ruled Monday in a stunning takedown of the drugmaker's $200 million March jury verdict....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.